世界の産後うつ病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Postpartum Depression Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4713
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、産後うつ病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（選択的セロトニン再取り込み阻害薬、セロトニンノルエピネフリン再取り込み阻害薬、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・産後うつ病治療の市場動向
・企業の競争状況、市場シェア
・産後うつ病治療の種類別市場規模（選択的セロトニン再取り込み阻害薬、セロトニンノルエピネフリン再取り込み阻害薬、その他）
・産後うつ病治療の用途別市場規模（病院、診療所、その他）
・産後うつ病治療の北米市場規模2016-2027（アメリカ、カナダ）
・産後うつ病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・産後うつ病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・産後うつ病治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・産後うつ病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Allergan、Anikem Laboratories、Cipla、Eli Lilly、Intas Pharmaceutical、Marinus Pharmaceuticals、Mylan、Pfizer、SAGE Therapeutics、Sun Pharmaceuticals）
・結論

Market Analysis and Insights: Global Postpartum Depression Treatment Market
The global Postpartum Depression Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Postpartum Depression Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Postpartum Depression Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Postpartum Depression Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Postpartum Depression Treatment market.

Global Postpartum Depression Treatment Scope and Market Size
Postpartum Depression Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Postpartum Depression Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Selective Serotonin Reuptake Inhibitors
Serotonin Norepinephrine Reuptake Inhibitors
Other Antidepressants

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan
Anikem Laboratories
Cipla
Eli Lilly
Intas Pharmaceutical
Marinus Pharmaceuticals
Mylan
Pfizer
SAGE Therapeutics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postpartum Depression Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Selective Serotonin Reuptake Inhibitors
1.2.3 Serotonin Norepinephrine Reuptake Inhibitors
1.2.4 Other Antidepressants
1.3 Market by Application
1.3.1 Global Postpartum Depression Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Postpartum Depression Treatment Market Perspective (2016-2027)
2.2 Postpartum Depression Treatment Growth Trends by Regions
2.2.1 Postpartum Depression Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Postpartum Depression Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Postpartum Depression Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Postpartum Depression Treatment Industry Dynamic
2.3.1 Postpartum Depression Treatment Market Trends
2.3.2 Postpartum Depression Treatment Market Drivers
2.3.3 Postpartum Depression Treatment Market Challenges
2.3.4 Postpartum Depression Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Postpartum Depression Treatment Players by Revenue
3.1.1 Global Top Postpartum Depression Treatment Players by Revenue (2016-2021)
3.1.2 Global Postpartum Depression Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Postpartum Depression Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Postpartum Depression Treatment Revenue
3.4 Global Postpartum Depression Treatment Market Concentration Ratio
3.4.1 Global Postpartum Depression Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Postpartum Depression Treatment Revenue in 2020
3.5 Postpartum Depression Treatment Key Players Head office and Area Served
3.6 Key Players Postpartum Depression Treatment Product Solution and Service
3.7 Date of Enter into Postpartum Depression Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Postpartum Depression Treatment Breakdown Data by Type
4.1 Global Postpartum Depression Treatment Historic Market Size by Type (2016-2021)
4.2 Global Postpartum Depression Treatment Forecasted Market Size by Type (2022-2027)

5 Postpartum Depression Treatment Breakdown Data by Application
5.1 Global Postpartum Depression Treatment Historic Market Size by Application (2016-2021)
5.2 Global Postpartum Depression Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Postpartum Depression Treatment Market Size (2016-2027)
6.2 North America Postpartum Depression Treatment Market Size by Type
6.2.1 North America Postpartum Depression Treatment Market Size by Type (2016-2021)
6.2.2 North America Postpartum Depression Treatment Market Size by Type (2022-2027)
6.2.3 North America Postpartum Depression Treatment Market Size by Type (2016-2027)
6.3 North America Postpartum Depression Treatment Market Size by Application
6.3.1 North America Postpartum Depression Treatment Market Size by Application (2016-2021)
6.3.2 North America Postpartum Depression Treatment Market Size by Application (2022-2027)
6.3.3 North America Postpartum Depression Treatment Market Size by Application (2016-2027)
6.4 North America Postpartum Depression Treatment Market Size by Country
6.4.1 North America Postpartum Depression Treatment Market Size by Country (2016-2021)
6.4.2 North America Postpartum Depression Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Postpartum Depression Treatment Market Size (2016-2027)
7.2 Europe Postpartum Depression Treatment Market Size by Type
7.2.1 Europe Postpartum Depression Treatment Market Size by Type (2016-2021)
7.2.2 Europe Postpartum Depression Treatment Market Size by Type (2022-2027)
7.2.3 Europe Postpartum Depression Treatment Market Size by Type (2016-2027)
7.3 Europe Postpartum Depression Treatment Market Size by Application
7.3.1 Europe Postpartum Depression Treatment Market Size by Application (2016-2021)
7.3.2 Europe Postpartum Depression Treatment Market Size by Application (2022-2027)
7.3.3 Europe Postpartum Depression Treatment Market Size by Application (2016-2027)
7.4 Europe Postpartum Depression Treatment Market Size by Country
7.4.1 Europe Postpartum Depression Treatment Market Size by Country (2016-2021)
7.4.2 Europe Postpartum Depression Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Postpartum Depression Treatment Market Size (2016-2027)
8.2 Asia-Pacific Postpartum Depression Treatment Market Size by Type
8.2.1 Asia-Pacific Postpartum Depression Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Postpartum Depression Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Postpartum Depression Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Postpartum Depression Treatment Market Size by Application
8.3.1 Asia-Pacific Postpartum Depression Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Postpartum Depression Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Postpartum Depression Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Postpartum Depression Treatment Market Size by Region
8.4.1 Asia-Pacific Postpartum Depression Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Postpartum Depression Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Postpartum Depression Treatment Market Size (2016-2027)
9.2 Latin America Postpartum Depression Treatment Market Size by Type
9.2.1 Latin America Postpartum Depression Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Postpartum Depression Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Postpartum Depression Treatment Market Size by Type (2016-2027)
9.3 Latin America Postpartum Depression Treatment Market Size by Application
9.3.1 Latin America Postpartum Depression Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Postpartum Depression Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Postpartum Depression Treatment Market Size by Application (2016-2027)
9.4 Latin America Postpartum Depression Treatment Market Size by Country
9.4.1 Latin America Postpartum Depression Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Postpartum Depression Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Postpartum Depression Treatment Market Size (2016-2027)
10.2 Middle East & Africa Postpartum Depression Treatment Market Size by Type
10.2.1 Middle East & Africa Postpartum Depression Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Postpartum Depression Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Postpartum Depression Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Postpartum Depression Treatment Market Size by Application
10.3.1 Middle East & Africa Postpartum Depression Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Postpartum Depression Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Postpartum Depression Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Postpartum Depression Treatment Market Size by Country
10.4.1 Middle East & Africa Postpartum Depression Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Postpartum Depression Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Postpartum Depression Treatment Introduction
11.1.4 Allergan Revenue in Postpartum Depression Treatment Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Anikem Laboratories
11.2.1 Anikem Laboratories Company Details
11.2.2 Anikem Laboratories Business Overview
11.2.3 Anikem Laboratories Postpartum Depression Treatment Introduction
11.2.4 Anikem Laboratories Revenue in Postpartum Depression Treatment Business (2016-2021)
11.2.5 Anikem Laboratories Recent Development
11.3 Cipla
11.3.1 Cipla Company Details
11.3.2 Cipla Business Overview
11.3.3 Cipla Postpartum Depression Treatment Introduction
11.3.4 Cipla Revenue in Postpartum Depression Treatment Business (2016-2021)
11.3.5 Cipla Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Postpartum Depression Treatment Introduction
11.4.4 Eli Lilly Revenue in Postpartum Depression Treatment Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Intas Pharmaceutical
11.5.1 Intas Pharmaceutical Company Details
11.5.2 Intas Pharmaceutical Business Overview
11.5.3 Intas Pharmaceutical Postpartum Depression Treatment Introduction
11.5.4 Intas Pharmaceutical Revenue in Postpartum Depression Treatment Business (2016-2021)
11.5.5 Intas Pharmaceutical Recent Development
11.6 Marinus Pharmaceuticals
11.6.1 Marinus Pharmaceuticals Company Details
11.6.2 Marinus Pharmaceuticals Business Overview
11.6.3 Marinus Pharmaceuticals Postpartum Depression Treatment Introduction
11.6.4 Marinus Pharmaceuticals Revenue in Postpartum Depression Treatment Business (2016-2021)
11.6.5 Marinus Pharmaceuticals Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Postpartum Depression Treatment Introduction
11.7.4 Mylan Revenue in Postpartum Depression Treatment Business (2016-2021)
11.7.5 Mylan Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Postpartum Depression Treatment Introduction
11.8.4 Pfizer Revenue in Postpartum Depression Treatment Business (2016-2021)
11.8.5 Pfizer Recent Development
11.9 SAGE Therapeutics
11.9.1 SAGE Therapeutics Company Details
11.9.2 SAGE Therapeutics Business Overview
11.9.3 SAGE Therapeutics Postpartum Depression Treatment Introduction
11.9.4 SAGE Therapeutics Revenue in Postpartum Depression Treatment Business (2016-2021)
11.9.5 SAGE Therapeutics Recent Development
11.10 Sun Pharmaceuticals
11.10.1 Sun Pharmaceuticals Company Details
11.10.2 Sun Pharmaceuticals Business Overview
11.10.3 Sun Pharmaceuticals Postpartum Depression Treatment Introduction
11.10.4 Sun Pharmaceuticals Revenue in Postpartum Depression Treatment Business (2016-2021)
11.10.5 Sun Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Postpartum Depression Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Selective Serotonin Reuptake Inhibitors
Table 3. Key Players of Serotonin Norepinephrine Reuptake Inhibitors
Table 4. Key Players of Other Antidepressants
Table 5. Global Postpartum Depression Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Postpartum Depression Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Postpartum Depression Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Postpartum Depression Treatment Market Share by Regions (2016-2021)
Table 9. Global Postpartum Depression Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Postpartum Depression Treatment Market Share by Regions (2022-2027)
Table 11. Postpartum Depression Treatment Market Trends
Table 12. Postpartum Depression Treatment Market Drivers
Table 13. Postpartum Depression Treatment Market Challenges
Table 14. Postpartum Depression Treatment Market Restraints
Table 15. Global Postpartum Depression Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Postpartum Depression Treatment Market Share by Players (2016-2021)
Table 17. Global Top Postpartum Depression Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postpartum Depression Treatment as of 2020)
Table 18. Ranking of Global Top Postpartum Depression Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Postpartum Depression Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Postpartum Depression Treatment Product Solution and Service
Table 22. Date of Enter into Postpartum Depression Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Postpartum Depression Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Postpartum Depression Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Postpartum Depression Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Postpartum Depression Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Postpartum Depression Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Postpartum Depression Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Postpartum Depression Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Postpartum Depression Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Postpartum Depression Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Postpartum Depression Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Postpartum Depression Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Postpartum Depression Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Postpartum Depression Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Postpartum Depression Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Postpartum Depression Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Postpartum Depression Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Postpartum Depression Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Postpartum Depression Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Postpartum Depression Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Postpartum Depression Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Postpartum Depression Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Postpartum Depression Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Postpartum Depression Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Postpartum Depression Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Postpartum Depression Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Postpartum Depression Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Postpartum Depression Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Postpartum Depression Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Postpartum Depression Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Postpartum Depression Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Postpartum Depression Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Postpartum Depression Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Postpartum Depression Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Postpartum Depression Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Postpartum Depression Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Postpartum Depression Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Postpartum Depression Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Postpartum Depression Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Allergan Company Details
Table 63. Allergan Business Overview
Table 64. Allergan Postpartum Depression Treatment Product
Table 65. Allergan Revenue in Postpartum Depression Treatment Business (2016-2021) & (US$ Million)
Table 66. Allergan Recent Development
Table 67. Anikem Laboratories Company Details
Table 68. Anikem Laboratories Business Overview
Table 69. Anikem Laboratories Postpartum Depression Treatment Product
Table 70. Anikem Laboratories Revenue in Postpartum Depression Treatment Business (2016-2021) & (US$ Million)
Table 71. Anikem Laboratories Recent Development
Table 72. Cipla Company Details
Table 73. Cipla Business Overview
Table 74. Cipla Postpartum Depression Treatment Product
Table 75. Cipla Revenue in Postpartum Depression Treatment Business (2016-2021) & (US$ Million)
Table 76. Cipla Recent Development
Table 77. Eli Lilly Company Details
Table 78. Eli Lilly Business Overview
Table 79. Eli Lilly Postpartum Depression Treatment Product
Table 80. Eli Lilly Revenue in Postpartum Depression Treatment Business (2016-2021) & (US$ Million)
Table 81. Eli Lilly Recent Development
Table 82. Intas Pharmaceutical Company Details
Table 83. Intas Pharmaceutical Business Overview
Table 84. Intas Pharmaceutical Postpartum Depression Treatment Product
Table 85. Intas Pharmaceutical Revenue in Postpartum Depression Treatment Business (2016-2021) & (US$ Million)
Table 86. Intas Pharmaceutical Recent Development
Table 87. Marinus Pharmaceuticals Company Details
Table 88. Marinus Pharmaceuticals Business Overview
Table 89. Marinus Pharmaceuticals Postpartum Depression Treatment Product
Table 90. Marinus Pharmaceuticals Revenue in Postpartum Depression Treatment Business (2016-2021) & (US$ Million)
Table 91. Marinus Pharmaceuticals Recent Development
Table 92. Mylan Company Details
Table 93. Mylan Business Overview
Table 94. Mylan Postpartum Depression Treatment Product
Table 95. Mylan Revenue in Postpartum Depression Treatment Business (2016-2021) & (US$ Million)
Table 96. Mylan Recent Development
Table 97. Pfizer Company Details
Table 98. Pfizer Business Overview
Table 99. Pfizer Revenue in Postpartum Depression Treatment Business (2016-2021) & (US$ Million)
Table 100. Pfizer Recent Development
Table 101. SAGE Therapeutics Company Details
Table 102. SAGE Therapeutics Business Overview
Table 103. SAGE Therapeutics Postpartum Depression Treatment Product
Table 104. SAGE Therapeutics Revenue in Postpartum Depression Treatment Business (2016-2021) & (US$ Million)
Table 105. SAGE Therapeutics Recent Development
Table 106. Sun Pharmaceuticals Company Details
Table 107. Sun Pharmaceuticals Business Overview
Table 108. Sun Pharmaceuticals Postpartum Depression Treatment Product
Table 109. Sun Pharmaceuticals Revenue in Postpartum Depression Treatment Business (2016-2021) & (US$ Million)
Table 110. Sun Pharmaceuticals Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postpartum Depression Treatment Market Share by Type: 2020 VS 2027
Figure 2. Selective Serotonin Reuptake Inhibitors Features
Figure 3. Serotonin Norepinephrine Reuptake Inhibitors Features
Figure 4. Other Antidepressants Features
Figure 5. Global Postpartum Depression Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Postpartum Depression Treatment Report Years Considered
Figure 10. Global Postpartum Depression Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Postpartum Depression Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Postpartum Depression Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Postpartum Depression Treatment Market Share by Regions (2022-2027)
Figure 14. Global Postpartum Depression Treatment Market Share by Players in 2020
Figure 15. Global Top Postpartum Depression Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postpartum Depression Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Postpartum Depression Treatment Revenue in 2020
Figure 17. Global Postpartum Depression Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Postpartum Depression Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Postpartum Depression Treatment Market Share by Type (2016-2027)
Figure 21. North America Postpartum Depression Treatment Market Share by Application (2016-2027)
Figure 22. North America Postpartum Depression Treatment Market Share by Country (2016-2027)
Figure 23. United States Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Postpartum Depression Treatment Market Share by Type (2016-2027)
Figure 27. Europe Postpartum Depression Treatment Market Share by Application (2016-2027)
Figure 28. Europe Postpartum Depression Treatment Market Share by Country (2016-2027)
Figure 29. Germany Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Postpartum Depression Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Postpartum Depression Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Postpartum Depression Treatment Market Share by Region (2016-2027)
Figure 39. China Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Postpartum Depression Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Postpartum Depression Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Postpartum Depression Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Postpartum Depression Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Postpartum Depression Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Postpartum Depression Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Postpartum Depression Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Allergan Revenue Growth Rate in Postpartum Depression Treatment Business (2016-2021)
Figure 59. Anikem Laboratories Revenue Growth Rate in Postpartum Depression Treatment Business (2016-2021)
Figure 60. Cipla Revenue Growth Rate in Postpartum Depression Treatment Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Postpartum Depression Treatment Business (2016-2021)
Figure 62. Intas Pharmaceutical Revenue Growth Rate in Postpartum Depression Treatment Business (2016-2021)
Figure 63. Marinus Pharmaceuticals Revenue Growth Rate in Postpartum Depression Treatment Business (2016-2021)
Figure 64. Mylan Revenue Growth Rate in Postpartum Depression Treatment Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Postpartum Depression Treatment Business (2016-2021)
Figure 66. SAGE Therapeutics Revenue Growth Rate in Postpartum Depression Treatment Business (2016-2021)
Figure 67. Sun Pharmaceuticals Revenue Growth Rate in Postpartum Depression Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の産後うつ病治療市場規模・現状・予測（2021年-2027年）

Global Postpartum Depression Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4713 2021年4月 93Pages
QYResearch社発行の本調査資料では、産後うつ病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（選択的セロトニン再取り込み阻害薬、セロトニンノルエピネフリン再取り込み阻害薬、その他）、用途別市場規模（病院、診療所、その他）、主要地域別...

世界の産後うつ病治療薬市場規模・現状・予測（2021年-2027年）

Global Postpartum Depression Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4712 2021年4月 90Pages
QYResearch社発行の本調査資料では、産後うつ病治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（選択的セロトニン再取り込み阻害薬、セロトニンノルエピネフリン再取り込み阻害薬、三環系抗うつ薬、モノアミン酸化酵素阻害薬）、用途別市場規模...

世界のうつ病治療用療法市場規模・現状・予測（2021年-2027年）

Global Depression Treatment Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z1799 2021年4月 133Pages
QYResearch社発行の本調査資料では、うつ病治療用療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、治療装置）、用途別市場規模（季節性情動障害（SAD）、大うつ病、気分変調性障害、産後うつ病、非定型うつ病、精神病性うつ病、その他...

世界のうつ病治療薬市場規模・現状・予測（2021年-2027年）

Global Depression Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z1798 2021年4月 96Pages
QYResearch社発行の本調査資料では、うつ病治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（SSRI、SNRI、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓...

世界の健康行動療法市場規模・現状・予測（2021年-2027年）

Global Behavioural Health Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0737 2021年4月 93Pages
QYResearch社発行の本調査資料では、健康行動療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（うつ病、不安神経症、統合失調症、双極性障害、アルコール使用障害、物質使用障害、摂食障害、心的外傷後ストレス障害、その他）、用途別市場規模（病...

世界の精神障害治療市場規模・現状・予測（2021年-2027年）

Global Mental Disorder Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3703 2021年4月 94Pages
QYResearch社発行の本調査資料では、精神障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、自助療法）、用途別市場規模（うつ病、双極性障害、統合失調症、認知症、心的外傷後ストレス障害、その他）、主要地域別市場規模（北米、アメ...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の産後うつ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Postpartum Depression Treatment Market The global Postpartum Depression Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…
世界の産後うつ病治療薬市場規模・現状・予測（2021年-2027年） Postpartum depression is a prevalent disorder affecting many women of reproductive age. Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depre…
世界のうつ病治療薬市場 2021：企業別、地域別、種類・用途別 The Depression Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
世界の可逆性モノアミン系抗うつ阻害剤（RIMA）市場規模・現状・予測（2021年-2027年） RIMAs are used as antidepressants. They work by reducing the activity of monoamine oxidase which is a chemical found throughout the body. Monoamine oxidase breaks down noradrenaline (also called norepinephrine) and serotonin and other chemicals made and used by the body and brain. These chemicals ar…
世界のうつ病治療用療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Depression Treatment Therapy Market The global Depression Treatment Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integri…